Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
The AAPS Journal|April 8, 2024
Leveraging Modeling and Simulation to Enhance the Efficiency of Bioequivalence Approaches for Generic Drugs: Highlights from the 2023 Generic Drug Science and Research Initiatives Public WorkshopArindom Pal, Fang Wu, Ross Walenga, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2021
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) containing a diazo precursorRun-Duo Gao, Niyada Hin, Eva Prchalová, et al.Pharmaceutics|January 25, 2025
Pharmacokinetic Evaluation of Neutral Sphinghomyelinase2 (nSMase2) Inhibitor Prodrugs in Mice and DogsArina Ranjit, Chae Bin Lee, Lukáš Tenora, et al.Drug Discovery Today|April 2, 2021
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseasesCarolyn Tallon, Kristen R Hollinger, Arindom Pal, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2025
A physiologically based biopharmaceutics modeling (PBBM) framework for characterizing formulation-dependent food effects: Paving the road towards fed state virtual BE studies for itraconazole amorphous solid dispersionsNiklas Rudolph, Nitin Charbe, David Plano, et al.ACS Medicinal Chemistry Letters|February 12, 2026
Discovery of N-Acetyltransferase 8-Like (NAT8L) inhibitors based on a N-Acylated (Piperidin-3-ylmethyl)-1,2,4-Oxadiazole ScaffoldMd Junayed Nayeen, Ajit G Thomas, Biswajit Kundu, et al.Journal of Medicinal Chemistry|November 3, 2022
Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding LigandToufiq Ul Amin, Rasha Emara, Arindom Pal, et al.Pharmaceutical Research|May 28, 2025
Using Model Master Files to Support Oral Drug Product Development and Regulatory SubmissionsYi-Hsien Cheng, Arindom Pal, Rebecca Moody, et al.Journal of Medicinal Chemistry|August 5, 2022
Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIPArindom Pal, Sadakatali Gori, Seung-Wan Yoo, et al.Pharmaceutics|October 27, 2022
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase IISadakatali S Gori, Ajit G Thomas, Arindom Pal, et al.Pageof 3